Ragosa Mark bought KNSA
November 2, 2026 · Form 4 insider transaction
Ragosa Mark bought 12,123 shares of Kiniksa Pharmaceuticals International, plc at $11.97 per share, a transaction worth $145.1K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
12,123
Price
$11.97
Total value
$145.1K
InsiderRagosa Mark
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeM: Option exercise
Transaction dateNovember 2, 2026
Filing dateNovember 3, 2026
Shares owned after48,001
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 29, 2026.